Manmei Long
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Cranial Nerve Ganglion Involvement Predicts Malignant Transformation of Plexiform Neurofibromas in Neurofibromatosis Type 1.
Journal: Plastic and reconstructive surgery
Published: July 17, 2025
STING is significantly increased in high-grade glioma with high risk of recurrence.
Journal: Oncoimmunology
Published: March 22, 2024
Oral Delivery of Gemcitabine-Loaded Glycocholic Acid-Modified Micelles for Cancer Therapy.
Journal: ACS nano
Published: September 17, 2023
RRM2 as a novel prognostic and therapeutic target of NF1-associated MPNST.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: April 18, 2023
ALYREF-mediated RNA 5-Methylcytosine modification Promotes Hepatocellular Carcinoma Progression Via Stabilizing EGFR mRNA and pSTAT3 activation.
Journal: International journal of biological sciences
Published: January 02, 2023
FOXM1 promotes neurofibromatosis type 1-associated malignant peripheral nerve sheath tumor progression in a NUF2-dependent manner.
Journal: Cancer gene therapy
Published: September 22, 2022
Concurrent inhibition of FAK/SRC and MEK overcomes MEK inhibitor resistance in Neurofibromatosis Type I related malignant peripheral nerve sheath tumors.
Journal: Frontiers in oncology
Published: April 01, 2022
Preclinical Assessment of MEK Inhibitors for Malignant Peripheral Nerve Sheath Tumors Reveals Differences in Efficacy and Adaptive Response.
Journal: Frontiers in oncology
Published: March 24, 2022
A drug-free nanozyme for mitigating oxidative stress and inflammatory bowel disease.
Journal: Journal of nanobiotechnology
Published: December 07, 2021
Screening to Identify an Immune Landscape-Based Prognostic Predictor and Therapeutic Target for Prostate Cancer.
Journal: Frontiers in oncology
Published: August 20, 2021
Last Updated: 09/26/2026